Safety of biologics approved for treating rheumatoid arthritis: analysis of spontaneous reports of adverse events.

Diogo Mendes, Carlos Alves, Francisco Batel Marques

Clin Rheumatol. 2013;32(8):1207-14.

2013

Sources of information used by regulatory agencies on the generation of drug safety alerts.

Carlos Alves, Ana Filipa Macedo, Francisco Batel Marques

Eur J Clin Pharmacol. 2013;69(12):2083-94.

2013

A meta-analysis of serious adverse events reported with exenatide and liraglutide: Acute pancreatitis and cancer

Carlos Alves, Francisco Batel Marques, Ana Filipa Macedo

Diabetes Res Clin Pract 2012;98(2):271-84

2012

Nurses’ spontaneous reporting of adverse drug reactions: expert review of routine reports

Diogo Mendes, Carlos Alves, Francisco Batel Marques

Journal of Nursing Management 2012 DOI: 10.1111/jonm.12003

2012

Implemented Data Mining and Signal Management Systems on Spontaneous Reporting Systems’ Databases and their Availability to the Scientific Community – A Systematic Review

Lima LMAV, Craveiro N, Dias PGP, and Batel Marques FJ

Curr Drug Saf. 2012;7(2):170-5

2012

Iatrogenia grave desconhecida, notificações e notificadores: resultados da actividade da Unidade de Farmacovigilância do Centro

Diogo Mendes, Carlos Alves, Francisco Batel Marques

Rev Port Med Geral Fam 2012;28:34-40

2012

Data sources on drug safety evaluation: a review of recent published meta-analysis

Alves C, Batel Marques F, Craveiro N, Macedo AF


J Epidemiol Community Health 2011;65:A77 doi:10.1136/jech.2011.142976c.30

2011

O papel dos farmacêuticos na farmacovigilância

Alves C, Craveiro N, Batel Marques, F


Revista da Ordem dos Farmacêuticos 2011

2011

Revisão das fontes de informação utilizadas em meta-análises de segurança

Alves C, Batel Marques F, Craveiro N, Macedo AF


10º Congresso da ANF

2011

Multiple drug exposure as a risk factor for the seriousness of adverse drug reactions

AF Macedo, C Alves, N Craveiro, F Batel Marques


J Nurs Manag 2011,19,395-399

2011

Safety evaluation of pharmacological interventions: a review of recent published meta-analysis

Alves C, Macedo AF, Craveiro N, Batel Marques F


Pharmacoepidemiol Drug Saf 2011;20:S351

2011

Increased severity of adverse drug reactions reported from hospitals.

Batel Marques FJ, Alves C, Craveiro N, Fontes-Ribeiro C, Macedo AF

Pharmacoepidemiol Drug Safe 2011;20:S330

2011

Hypersensitivity syndrome due to drug exposure – ten years case review.

Craveiro N, Alves C, Fontes Ribeiro C,Batel Marques FJ

Pharmacoepidemiol Drug Saf 2011;20:S332-S333

2011

Omissão de fármacos modificadores do risco cardiovascular em idosos admitidos numa Unidade de Acidentes Vasculares Cerebrais.

Borges EP, Macedo AF

Rev Port Clin Geral 2011;27:140-150

2011

Apixaban and rivaroxaban safety after hip and knee arthroplasty: a meta-analysis.

Alves C, Macedo AF, Batel Marques F

Pharmacotherapy 2011;31(10):357e

2011

Fecundação in vitro em Portugal: um estudo de custo-efectividade.

Silva V, Pita Barros P, Lourenço O, Batel-Marques F.

Rev Port Farmacoter 2011;3:139-153

2011

Data sources on drug safety evaluation: a review of recent published meta-analysis.

Alves C, Batel Marques F, Macedo AF

Pharmacoepidemiol Drug Saf 2012;21(1):21-33

2011

Apixaban and rivaroxaban safety after hip and knee arthroplasty: a meta-analysis.

Alves C, Batel-Marques F, Macedo AF.

J Cardiovasc Pharmacol Therap 2011 1 Dec. doi: 10.1177/1074248411427402

2011